Sabine Mueller, Md, Phd
Clinical trials sponsored by Sabine Mueller, Md, Phd, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New pill shows promise against childhood brain tumor Results expected Mar 2027 (estimated)
- New hope for kids with deadly brain cancer? drug ONC206 enters human trials Results expected May 2027 (estimated)
-
New hope for kids with aggressive brain cancer: hormone therapy plus chemo
Disease control Recruiting nowThis study tests a thyroid hormone called liothyronine (L-T3) alone or with standard chemotherapy in children and young adults whose medulloblastoma has come back or worsened. The goal is to see if adding L-T3 can help control the cancer better. About 69 participants will take pa…
Phase 1/2 • Sponsor: Sabine Mueller, MD, PhD • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Hope for kids with rare brain cancer: new drug combo trial launches
Disease control Recruiting nowThis study tests a combination of two drugs, gemcitabine and paxalisib, in children, teens, and young adults whose atypical teratoid rhabdoid tumor (ATRT) has come back or gotten worse. The goal is to find a safe dose and see if the drugs can control the tumor. About 29 participa…
Phase 2 • Sponsor: Sabine Mueller, MD, PhD • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New hope for kids with deadly brain cancer? drug ONC206 enters human trials
Disease control Recruiting nowThis early-phase trial tests a new drug called ONC206 in children and young adults with diffuse midline glioma or other recurrent brain tumors. The drug aims to kill cancer cells by causing stress in them, without harming healthy cells. Researchers are looking for the safest dose…
Phase 1 • Sponsor: Sabine Mueller, MD, PhD • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New pill shows promise against childhood brain tumor
Disease control Recruiting nowThis study is testing a drug called Tovorafenib for children and young adults with craniopharyngioma, a rare, non-cancerous brain tumor that can cause serious health problems. The drug is taken by mouth and works by blocking a protein that helps the tumor grow. The trial aims to …
Phase 2 • Sponsor: Sabine Mueller, MD, PhD • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC